Drug intelligence / Profile preview

ursodeoxycholic acid + thiamine + riboflavin

Development stage
Unknown
Lead developer
Daewoong Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

**Ursodeoxycholic acid + thiamine + riboflavin** is an oral fixed-dose soft-capsule combination containing ursodeoxycholic acid 50 mg, thiamine nitrate or mononitrate 10 mg, and riboflavin 5 mg. It is marketed as **Ursa-S** and related Ursa products by Daewoong for improvement of liver function in chronic hepatic disease and symptoms associated with hepatic dysfunction, including fatigue, dyspepsia, and anorexia. Ursodeoxycholic acid is a hydrophilic bile acid that improves bile composition and bile flow, reduces bile-acid-mediated hepatocyte injury, and has cytoprotective and anti-apoptotic effects; thiamine and riboflavin support intermediary energy metabolism as vitamin B cofactors. The exact three-component product was studied in a completed Phase 4 fatigue trial in patients with elevated liver-function tests and or fatty liver disease. ([daewoongcorp.kr](https://daewoongcorp.kr/www_corp/english/product/prod_view.asp?idx=123&mn=5b11))

Brand names
UrsaUrsa-S
Other names
ursodeoxycholic acid + riboflavin + thiamineursodeoxycholic acid + thiamine mononitrate + riboflavinursodeoxycholic acid + vitamin B1 + vitamin B2ursodiol + thiamine + riboflavin
02

Targets

ABCB11 (Bile salt export pump)

Beyond the preview

Go deeper on ursodeoxycholic acid + thiamine + riboflavin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ursodeoxycholic acid + thiamine + riboflavin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call